Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Is it possible to predict list overruns in a NHS day surgery unit?

Autor: Faiz O (AUTHOR), Mcguire AJ (AUTHOR), Tekkis P (AUTHOR), Rennie JA (AUTHOR), Baskerville P (AUTHOR), Leather AJM (AUTHOR)

Publikováno v: Ambulatory Surgery. Sep2007, Vol. 13 Issue 3, p15p-15p. 1p.

Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.

Autor: Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK. Electronic address: u.menon@ucl.ac.uk., Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK; Department of Women's Cancer, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK., Burnell M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Ryan A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Singh N; Department of Cellular Pathology, Barts Health NHS Trust, London, UK., Manchanda R; Department of Gynaecological Oncology, Barts Health NHS Trust, London, UK; Wolfson Institute of Population Health, CRUK Barts Cancer Centre, Queen Mary University of London, London, UK., Kalsi JK; AGE Research Unit, School of Public Health Imperial College London, London, UK., Woolas R; Department of Gynaecological Oncology, Queen Alexandra Hospital, Portsmouth, UK., Arora R; Department of Cellular Pathology, University College London Hospitals NHS Trust, London, UK., Casey L; Department of Cellular Pathology, Barts Health NHS Trust, London, UK., Dawnay A; Department of Clinical Biochemistry, Barts Health NHS Trust, London, UK., Sharma A; Department of Obstetrics and Gynaecology, University Hospital of Wales, Cardiff, UK., Williamson K; Department of Gynaecological Oncology, Nottingham University Hospitals, Nottingham, UK., Apostolidou S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK., Fallowfield L; Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, UK., McGuire AJ; London School of Economics and Political Science, London, UK., Campbell S; Create Health, London, UK., Skates SJ; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Jacobs IJ; Department of Women's Cancer, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2023 Sep; Vol. 24 (9), pp. 1018-1028.